After four months of restless work, researchers in Vietnam are getting closer to produce a vaccine for the novel coronavirus.
According to a June 26 news on vietnamnews.vn, a vaccine for the virus that is being developed by state-owned vaccine manufacturer VABIOTECH Co. could generate relatively high immune response.
Two batches of 50 mice injected with Covid-19 candidate vaccine were sent to the National Institute of Hygiene and Epidemiology (NIHE) on May 15 and 16, respectively.
“Comparing the mice serum injected with the inactivated wild-type virus, the NIHE determined that these serum samples gave antibody responses, some of which were relatively high,” the report noted.
A top official from NIHE said that the milestone is a foundation to develop a completed vaccine.
VABIOTECH researcher Mac Van Trong was quoted as saying by vietnamenews.vn that the results which were released in mid-June proved that they are on the right track to develop the vaccine for Covid-19.
Trong added that the biotech company has already finished the first phase of the vaccine development two months early, emphasizing that this phase was the most important in the development of the Covid-19 vaccine.
Next phase will be completed and stabilized to meet requirements for human trials.
“It takes about nine to 12 months to complete the candidate vaccine. On average, it takes 10 years to develop and produce a vaccine. So, it is a great achievement to find a vaccine in a period of 18 to 24 months,” he added.